Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
Thase
Michael E
ME
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, S 3811 O'Hara St., Pittsburgh, PA 15213-2593, USA. thaseme@msx.upmc.edu
D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D015201:Meta-Analysis as Topic; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000928:Antidepressive Agents; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors